Field evaluation of a second-generation cytometer UF-100 in diagnosis of acute urinary tract infections in adult patients  by Manoni, F. et al.
ORIGINAL ARTICLE
Field evaluation of a second-generation cytometer UF-100 in diagnosis of
acute urinary tract infections in adult patients
F. Manoni, S. Valverde, F. Antico, M. M. Salvadego, A. Giacomini and G. Gessoni
Clinical Pathology Department, ASL 14, Clinical Pathology Laboratory, Civil Hospital, Via Madonna
Marina 500, 30019 Chioggia (Venice), Italy
Aims The authors evaluated the analytical performance of the SysmexUF-100 cytometer
vs. the diagnosis of urinary tract infections (UTI).
Methods We considered 2010 subjects, aged between 18 and 78, 870 males and 1140
females. The majority (90.2%) of the samples were voided urine specimens collected by
using themidstream technique. Each sample was subjected tomicrobiological evaluation
(cultureþ residual antibacterial activity), dipstick tests, UF-100 examination and micro-
scopic observation. In order to obtain a ﬁnal diagnosis of UTI these laboratory results
were taken into consideration togetherwith clinical data and patients’ characteristics. The
analytical performance of the laboratory tests was obtained by adopting this diagnosis as
standard practice.
Results Out of the total 2010 subjects considered a clinical diagnosis of UTI was obtained
in 529 cases (26.32%). The UF-100-based screening had sensitivity, 0.94; speciﬁcity, 0.93;
positive predictive value, 0.83; negative predictive value, 0.98; and correctly classiﬁed
incidence, 0.93.
Conclusions In our experience the results of the UF-100-based screening show a very
good correlation with the diagnosis of acute UTI in adults patients.
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INTRODUCTION
The main clinical manifestations of urinary tract
infections (UTI) are dysuria, fever, suprapubic
heaviness and pain; a microbiological examination
of a urine sample is usually necessary to establish
the aetiology of the disease [1]. For laboratory
diagnosis of UTI it is of great importance to estab-
lish a deﬁnition of signiﬁcant bacteriuria and
pyuria. For bacteriuria, counts of more of 100 000
colony-forming units (CFU)/mL are usually con-
sidered signiﬁcant [2,3]. For pyuria usually more
than 5–10 white blood cells per high-power ﬁeld
(HPF) are considered signiﬁcant [3].
In the clinical laboratory several screening tests
have been devised for the rapid diagnosis of UTI,
these tests can be classiﬁed into non-cultural meth-
ods and cultural methods [4]. The most common
approach to a non-culture screening for UTI is the
use of reagent dipsticks to detect the presence of
nitrite and leucocyte esterase [5,6]. False negatives
may result in the presence of infections by bacteria
which do not produce nitrite, i.e. group D enter-
ococci [7]. False positives may result in the pre-
sence of ascorbic acid, drug interference and
overgrowth with nitrite-producing bacteria [8].
The aim of this study is to evaluate the feasibility
of screening for the rapid diagnosis of UTI by
using automated instrumentation for the study
of the corpuscular parts of urinary samples. We
evaluated a second-generation ﬂow cytometer,
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Sysmex UF-100 (Toa Medical Electronics, Kobe,
Japan) vs. the diagnosis of UTI supported by
laboratory data from urine culture, microscopic
examination, routine chemical analysis, and clin-
ical and demographic data such as age, sex, symp-
toms, urinary tracts abnormalities, and suspected
diagnosis.
MATERIALS AND METHODS
Patient selection
We considered 2010 patients, aged between 18 and
78 years (mean 56.4 years), whose recently col-
lected urine samples were submitted to our labora-
tory for diagnostic microbiological examination
between January and August 1999. For each of
these patients, their age, gender, symptoms, pre-
sence of underlying diseases (i.e. urinary tract
anomalies or diabetes), therapy, etc. were record-
ed. The samples were obtained from outpatients
(1130; 496 males and 634 females) and inpatients
(880; 374 males and 506 females). The majority
(1812; 90.2%) of samples were voided urine speci-
mens collected using themidstream technique; 198
(9.8%) samples were collected through a bladder
catheter. The samples were collected in sterile
containers and a 12-mL aliquot was transferred
into test tubes and analysed within 1 h.
Chemical and physical examination
Dipstick analysis of urine samples was carried out
before ﬂow cytometry analysis by using URIFLET
strips and two Super Aution automated reﬂec-
tance photometer (Menarini, Florence, Italy). The
strips included reagent pads for semiquantita-
tive assessment of relative density, pH, leucocyte
esterase, nitrite, protein, glucose, ketones, urobili-
nogen, bilirubin and haemoglobin [9]. Each equip-
ment could perform about 225 tests/h.
Microscopic examination
The classic microscopic examination was per-
formed according to the NCCLS/95 guideline.
After UF-100 analysis, each urine specimen
(10mL) was centrifuged at 400 g for 10min, and
9.5mL of supernatant was discharged. In each
specimen at least 20 random microscopic ﬁelds
were examined at 400 (HPF) by the same experi-
enced technician and the mean number of cells/
HPF was calculated [10].
Culture of urine specimens
For microbiological examination, samples were
inoculated on agar plates by using 0.001mL cali-
brated loops within 4 h. Both selective [McConkey
(McC) agar and colistin–nalidixic acid blood (CNA)
agar] and non-selective cystine lactose electrolyte
deﬁcient agar (CLED) media were adopted. After
24 h at 37 8C cultures were quantiﬁed, in CLED
plates, as follows: from 0 to 10 colonies (under
10 000CFU/mL, negative); from 11 to 100 colonies
(from 10 000 to 100 000CFU/mL, ‘moderate num-
ber’); over 100 colonies (over 100 000CFU/mL,
‘largenumber’) [11,12]. Incultureswithasigniﬁcant
bacteriuria a biochemical identiﬁcation and an
investigation into the sensitivity to antimicrobial
drugs was performed using an automated system:
DADE Microscan (Dade International Inc. Sacra-
mento CAUSA) [13,14]. In each samplewe studied
the residual antibacterial activity (RAA) [15].
UF-100 examination
The Sysmex UF-100 is a second-generation auto-
mated analyser that performs an analysis of the
formed elements in urine by using ﬂow cytometry,
this instrumentation is able to test 100 samples
every hour. The UF-100 analyser sucks in 0.8mL
of uncentrifuged urine and performs the analysis
[16]. The sample is transferred to the reaction
unit and then is diluted four times with a special
diluent to dissolve the crystalline contents. Then a
mixture of two dyes, carbocyanine and phenan-
thridine, is added to the solution and the stain-
ed sample is entered into the ﬂow cell where the
urine’s conductivity is measured. After this step
the sample is entered into a ﬂow cell to form a
sheath ﬂow which is created by passing a sheath
liquid irradiated by an argon laser beam. The
ﬂuorescence, the pulse intensity and the pulse
width of the forward-scattered light are measured
[17]. These measures, together with the imped-
ance data, are converted into three ranks of formed
elements (Scattergram) [18]: erythrocytes, leuco-
cytes, epithelial cells and bacteria are recognized
from the scattergram of the forward-scattered
light and the ﬂuorescent light intensity. Epithelial
cells are classiﬁed according to the forward-
scattered pulse width and the ﬂuorescence pulse
width. For discrimination between casts and
mucus it is important to consider the ﬂuorescence
pulse width. For erythrocytes, leucocytes, bacteria
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and epithelial cells, the scattergrams and the
counting result, expressed as a number of cells/
mL, can be printed. Thereafter, the analyzer gives
the operator further information about the
morphology of red cells, the presence of sperm
and/or pathological casts, etc. [19,20]. For the
diagnosis of UTI using UF-100 we considered
only two parameters among those previously
described: quantiﬁcation of bacteriuria and leuco-
cyturia. In this studywe considered that the cut-off
value for UF-100 evaluation of pyuria is 25 cells/
mL [21] and for bacteriuria, 100 000 cells/mL
[22].
Statistical analysis
In this study the standardwas the diagnosis of UTI
obtained from integrating clinical considerations
with laboratory results. In order to assess the
analytical performance of UF-100 screening for
bacteriuria and pyuria in the diagnosis of UTI
we assessed the mean prevalence of this disease
in the considered population (26.32%). Our statis-
tical analysis included evaluation of speciﬁcity
(SP), sensitivity (SE), positive predictive value
(PPV), negative predictive value (NPV), and cor-
rect classiﬁcation incidence (CCI). For comparison
of means we adopted the Student’s t-test; for
comparison of proportions we adopted the Pear-
son w2 test; a value <0.05 is considered signiﬁcant
[23].
RESULTS
Of the 2010 patients considered, 529 (26.32%) were
thought to be affected by a UTI. The prevalence of
subjects affected by UTI was 33.52% among inpa-
tients vs. 20.71% among outpatients; this differ-
ence was statistically signiﬁcant (P< 0.05). Among
the patients with UTI, 473 (89.41%) had bacteriuria
over 100 000CFU/mL and therefore, these
patients matched the classic microbiological cri-
teria for a diagnosis of UTI. In 56 (10.59%) patients
bacteriuria was between 10 000 and 100 000CFU/
mL, but these subjects were considered as being
affected by a UTI because of clinical considera-
tions; 34 of these samples were positive for RAA
and were still symptomatic despite the antimicro-
bial therapy. In these patients we observed a
persistent infection sustained by yeast in eight,
by fastidious Gram-positive organisms in 12 and
by fastidious Gram-negative bacteria in 14.
Among the 1491 subjects not considered affected
by UTI, 1014 had bacteriuria under 10 000CFU/
mL, 432 between 10 000 and 100 000CFU/mL and
35 had mixed bacteriuria with a microbial count
over 100 000CFU/mL. These 35 samples were
considered not to be diagnostic for UTI because
of contamination. In these samples we observed
more than three bacterial strains, none of which
accounted for almost 80% of the colonies [24].
These results are described in Table 1. By using
the classic dipstick screening based on detection of
Bacteriuria
(CFU/mL) Considerations Number %
Patients without urinary tract infections
<10 000 Negative 1.014 50.45
10–100 000 Non-significant bacteriuria 432 21.49
>100 000 Mixed bacteriuria:
contamination
35 1.74
Patients with urinary tract infections
<100 000 Bacteriuria considered
significant because of
clinical considerations
56 2.78
>100 000 Significant bacteriuria 473 23.53
In the study population (2010 subjects) 529 patients (26.32%) were considered to
be affected by a urinary tract infection.
Usually urine samples with bacteriuria under 10 000CFU/mL are considered
negative and bacteriuria under 100 000CFU/mL is considered not significant.
In our study we considered 35 samples with bacteriuria over 100 000CFU/mL
not significant for UTI because of the observation of a mixed bacteriuria.
In our study we considered 56 samples with bacteriuria under 100 000CFU/mL:
significant for UTI because of clinical considerations.
Table 1 Description of the final di-
agnosis of UTI in the considered
population
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nitrites and leucocyte esterase in the urine sample
we observed 171 (8.51%) false negatives and 184
(9.15%) false positive results. For this screening SE
was 0.64, SP was 0.88, PPVwas 0.63, NPV was 0.89
and CCI was 0.82.
The combination of the quantitative determina-
tion of bacteriuria and pyuria by UF-100 showed
29 (1.44%) false-negative results and 102 (5.07%)
false-positive results. This combined screening
had an SE of 0.94, an SP of 0.93, a PPV of 0.83,
an NPV of 0.98 and a CCI of 0.93, with a clinical
diagnosis of UTI. These results are shown in
Table 2.
DISCUSSION
Usually in clinical laboratory practice a great num-
ber of samples are submitted for urinalysis and
microbiological examination; around 70% of these
samples are not compatible with a diagnosis of
UTI. In this study the diagnosis of UTI obtained
from clinical considerations and laboratory results
was compared with the analytical performances of
the simple evaluation of bacterial growth on CLED
agar, the dipstick screening for nitrite and esterase,
and the quantitative evaluation of bacteriuria and
pyuria obtained by using UF-100. By using the
simple evaluation of the number of CFU/mL
observed on CLED agar we observed 35 (1.74%)
false-positive results and 56 (2.79%) false-negative
results. In our experience this test had an SE of
0.89, an SP of 0.98, a PPV of 0.93, an NPV of 0.96
and a CCI of 0.95. The analytical performance of
dipstick screening is relatively satisfactory. There
were 171 (8.51%) false-negative results and 184
(9.15%) false-positive results. In our experience
the dipstick screening SE was 0.64, SP was 0.88,
PPV was 0.63, NPV was 0.89 and CCI was 0.82;
these results appeared to be in good accordance
with data from the literature [5–7,11–13]. Quanti-
tative determination of bacteriuria and pyuria by
UF-100 showed 29 (1.44%) false-negative results
and 102 (5.07%) false-positive results. This screen-
ing had an SE of 0.94, an SP of 0.93, a PPV of 0.83,
an NPV of 0.98 and a CCI of 0.93. Our results show
that the UF-100 screening has a better correlation
with the diagnosis of UTI, not only in comparison
with the dipstick screening test, but also in com-
parison with the simple evaluation of bacterial
growth on CLED agar. In our study this screening
demonstrated an NPV of 0.98. So a subject without
signiﬁcant leucocyturia and bacteriuria in UF-100
screening has a 98% probability of being free from
UTI.
These data are of great practical importance.
Indeed they may be signiﬁcant in establishing a
routine to dismiss microbiological examination of
urine specimens with a negative result in UF-100
screening [25–27]. In our experience the use of UF-
100 as a screening test for UTI showed only 29
false-negative and 102 false-positive results.
Among the 29 false-negative results, 20 were
observed in patients with UTI but with low bac-
terial counts (<10 000CFU/mL). In these 20 sam-
ples the evaluation of the bacterial growth (cut-off
at 100 000CFU/mL) on CLED agar gave a negative
result too. We observed only nine false-negative
results in samples with high bacterial counts
(>100 000CFU/mL). Among the 102 false-positive
results, 35 were because of the presence of poly-
microbial ﬂora contaminating the urine samples, 59
were due to detection of pyuria (but not bacteriu-
ria) without UTI; 51 of these subjects were female
so it is possible that the leucocytes had come from
the genital mucosae rather than from the urinary
tract. In eight subjects UF-100 gave a false-positive
result because of the detection of bacteriuria with-
out pyuria and without UTI, probably because of
multiplication of bacteria due to inappropriate
handling or storage of the urine sample.
Table 2 Analytical performance of
various laboratory parameters with
clinical diagnosis of UTI
SE SP PPV NPV CCI
Dipstick screening: nitriteþ esterase 0.64 0.88 0.63 0.89 0.82
Quantitative valuation of bacterial
growth on CLED agar
0.89 0.98 0.93 0.96 0.95
LeucocyturiaþBacteriuria UF-100 0.94 0.93 0.83 0.98 0.93
We considered the analytical performance of the dipstick screening (evaluation of
nitrite reduction and leucocyte esterase), the simple quantitative evaluation of
bacterial growth on CLED agar, and the quantitative evaluation of bacteriuria
and pyuria obtained from UF-100 analyser.
SE, sensitivity; SP, specificity; PPV, positive predictive value; NPV, negative
predictive value; CCI, correct classified incidence.
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In Figure 1 a ﬂow-chart for diagnosis of UTI
based on the results of this study was suggested.
We considered 2010 urine samples, out of which
1408 (70.05%) were negative using the UF-100
screening. For all these samples it was possible
to produce results within a few minutes of the
submission of the sample for a microbiological
evaluation. Out of these samples 1379 were actu-
ally (68.61%) negative. Twenty-nine samples gave
false-negative results (1.44%); out of these, nine
(0.45%) came from patients receiving antibacterial
treatment for a previous diagnosis of UTI (these
patients gave a positive result for the RAA test in
urine). The UF-100-based screening failed in only
20 samples (0.99%) for the diagnosis of UTI in
untreated patients. For these subjects, the short
time required for the laboratory results, allows
the physician to critically assess the laboratory
data and to decide on the submission of a new
sample in order to obtain a complete, careful
microbiological examination before starting any
treatment. Obviously, the submission of these cri-
tical samples must be discussed with the clinical
pathologist. On the other hand, 602 samples
(29.95%) were positive using the UF-100 screening;
all these samples were submitted to a culture
examination; in 500 samples (20.88%) we observed
a signiﬁcant bacterial growth. These were true
positive results. In all these samples a biochemical
and serological identiﬁcation of the bacterial strain
was performed, together with an in vivo suscept-
ibility test for antibacterial drugs; a complete result
may be available to the physician within 48–72 h of
the sample’s submission. In 102 samples (5.07%)
we did not observe signiﬁcant bacterial growth:
these were false-positive results. In 35 (1.74%) of
these false-positive results we observed a polymi-
crobial ﬂora, and so there was no need for further
tests. Perhaps in these subjects the need for a
correctly recovered new sample should be evalu-
ated. In eight (0.4%) samples we observed the
presence of bacteriuria without pyuria. The
authors suggest that in these samples the incon-
gruent result may be due to an incorrect handling
of the sample used for the UF-100 screening. In 59
(51 female) samples (2.94%) we observed a ‘sterile
pyuria’; the absence of signiﬁcant bacteriuria was
conﬁrmed by culture examination but the pre-
sence of leucocytes remained unexplained. It is
possible that these white blood cells came from the
mucosae of the female genital tract. These samples
need further examination because it is possible
that an infection was sustained from fastidious
micro-organisms such asNeisseria gonoree, Chlamy-
dia trachomatis, Microbacterium tuberculosis.
In conclusion, in our experience the results of the
UF-100-based screening are comparable to data
obtained from culture examination based on the
simple evaluation of bacterial growth on CLED
agar (cut-off 100 000CFU/mL). The classic culture
method requires 24 h to produce a result, whereas
the UF-100-based screening gives a result within a
few minutes, with obvious beneﬁt for patients and
physicians. In our clinical laboratory the examina-
tion of the urine using the UF-100 system is eco-
nomical because the cost of this test is only
0.69 Euro, inclusive of equipment rental and re-
agents. Moreover, the quantiﬁcation of bacteriuria
and pyuria used in this study as a screening test for
UTI does not call for a new and expensive test to be
introduced in the clinical laboratory, involving
extra time, labour and costs, but it is a by-product
of the examination of the corpuscular portion of
urine sampleswhen using a ﬂow cytometer [28,29].
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